Sarah Robinson is the Deputy Consul General to the British Consulate-General Hong Kong and Macao. This is her third tour to Hong Kong having previously served as Consul, Economics and Trade Policy, in 2019, and Second Secretary Political in 2004. Sarah joined the Foreign and Commonwealth Office in 2000. She has previously served as Deputy Head of Consular Assistance and headed up the Overseas Passport Management Unit, the Detainee Inquiry Unit, and the Prevent Counter Terrorism Team. She also served as a Desk Officer on Cyprus and on EU Public Diplomacy. Outside the FCDO Sarah worked for the Department for Education and Employment and also spent time seconded to the EU Commission and as a Parliamentary Assistant in the European Parliament. She has a degree in European Politics and Legislative Studies and is currently studying for a masters in Executive Coaching. Sarah speaks Cantonese and reads Chinese.

Alia Rahman is founder of Amplexd Therapeutics, an early-stage biotech company that has developed two novel, non-invasive treatments for HPV-induced cervical dysplasia, the precursor to cervical cancer. In 2007, Alia was herself diagnosed with the late-stage, high-grade cervical dysplasia. After undergoing a traumatic surgery, Alia continued to live with low-grade dysplasia. A decade later, another flare up to high-grade motivated her to develop an effective topical treatment in order to avoid further surgeries. In her kitchen, she combined two APIs and treated her own lesions, resulting in the first normal screening in over a decade. This finding formed the basis of Amplexd. Within six months, Amplexd had developed and patented two treatments: an intravaginal suppository and photodynamic therapy system as alternatives to “watch and wait” and invasive surgery, addressing all stages of dysplasia. Alia’s hopes are two-fold: to make non-invasive, low-cost treatments readily accessible to women all over the globe where screening and treatment options are scarce; and secondly, to see non-invasive therapies become the norm in HPV-care and gynecology more broadly. Alia holds a BASc in Engineering from the University of Waterloo and currently resides in Montreal, Canada. Alia is a multi-time medtech founder.

Dr. Ricky CHIU, Founder, Chairman, and CEO of PHASE Scientific International Limited, is an esteemed innovator and the lead inventor of PHASiFY™. With over 55 patents granted, PHASiFY™ has revolutionized low-concentration target molecule detection in diagnostics, advancing liquid biopsy and rapid point-of-care testing for early cancer and infectious disease detection. Ricky's efforts in leveraging his technologies for COVID diagnostics, including the first COVID rapid antigen test in Greater China to obtain FDA emergency use authorization, have earned him numerous prestigious recognitions. He has been honored with awards such as Ten Outstanding Young Persons of the World, Ten Outstanding Young Persons in Hong Kong, Young Industrialist of Hong Kong, and HKSAR Chief Executive's Commendation for Community Service. Through PHASiFY™, Ricky has made significant advancements in urine genetic testing. This technology can process and concentrate large urine volumes, extracting over 10 times more target analytes than the industry standard. It has led to the development of the world's first self-collection HPV urine test for cervical cancer, surpassing pap smear limitations. This innovative diagnostic process empowers women to conveniently manage their cervical health by detecting HPV in a non-intrusive and painless way.

Dr. CHOI is a female biomedical scientist. She has a deep interest in tackling women's diseases. Her Ph.D. study focuses on ovarian cysts formation and the migration of ovarian cancer cells. With new cell culture modeling and animal model, she revealed the pathogenesis of ovarian cancer, the deadliest gynecologic cancer which causes 150,000 death worldwide. After she completed her Ph.D. study, she pursued postdoctoral training at the renowned OB/GYN department at Brigham and Women's Hospital, Boston MA. She continued the study on ovarian cancer, including finding new biomarkers for diagnosis and prognosis of ovarian cancer and investigating ovarian cancer stem cells. Being a female scientist, she has a vision of developing biotechnology to facilitate treatment, diagnosis, and management of women's diseases, including female reproductive system cancer and fungal /viral/ bacterial infections. She also wants to help women to understand more about their health status fertility profile. Therefore, she founded WomenX Biotech Limited which is dedicated to developing a wide scope of solutions for tackling women's diseases.

Jessica has over 20 years of leadership experience in the media and financial service sector. As Executive Vice Chair of South China Financial Holdings, she leads the financial services business of South China Group. Jessica launched her namesake magazine JESSICA in 2000 which soon became the highest circulation women’s magazine in Hong Kong, with the aim of inspiring women to pursue their life dreams. Later she established the JESNetwork, a community founded on the JESSICA Most Successful Women Award, with the mission of connecting, inspiring and empowering women, to create a collaborative space for women in entrepreneurship, sustainability, technology and sport. For over two decades, JESSICA has been a beacon of empowerment for women in Hong Kong and beyond, and to further her mission and vision, ensuring that the impact remains authentic and powerful, The JESSICA Company was established as a standalone corporate entity in 2024. The Jessica Charitable Foundation was formed in 2012 as a charitable institution under s.88 of the Inland Revenues Ordinance, with the aim of supporting social initiatives empowering women and youths. The annual JESSICA Run is the foundation’s signature fundraiser and family and amateur runners’ event, to arouse awareness on physical and mental health, to raise funds for non-profit organisations in Hong Kong. Jessica sits on various women and youth support associations, including the position of Board Member and Treasurer of the The International Women’s Forum Hong Kong Chapter, and Ambassador of the Ocean Park Conservation Foundation, Hong Kong. She holds a Bachelor of Laws degree from King’s College London, University of London in the United Kingdom and was admitted to the Hong Kong Bar in 2006. She is an associate member of the Chartered Institute of Management Accountants and a member of the Standing Committee of the 13th Hebei Provincial Committee of the Chinese People’s Political Consultative Conference. She also previously served as a member of the 11th, 12th and 13th Tianjin Municipality Committee of the Chinese People’s Political Consultative Conference.